In addition, Molinari et al., considered that the use of PTEN as a prognostic or predictive marker in CRC is also currently under discussion, for several reasons, including: (1) the scope of the study; (2) the criteria for inclusion for patients; and (3) the techniques used to measure PTEN alteration 16. The gene discussed is PTEN; the disease is colorectal carcinoma.